Archives

  • 2026-11
  • 2026-10
  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2'3'-cGAMP (sodium salt): Precision STING Agonist for Inn...

    2026-02-20

    2'3'-cGAMP (sodium salt): Precision STING Agonist for Innate Immunity

    Principle and Setup: Unleashing the Power of cGAS-STING Signaling

    2'3'-cGAMP (sodium salt) stands at the forefront of STING-mediated innate immune response research. As a naturally occurring cyclic dinucleotide synthesized by cGAS upon sensing cytosolic double-stranded DNA, it functions as a high-affinity STING agonist (Kd = 3.79 nM), outperforming other cyclic dinucleotides in both potency and specificity.[1] Upon binding STING, it triggers a cascade involving TBK1 and IRF3, culminating in robust type I interferon induction—a hallmark of antiviral innate immunity and a foundation for cancer immunotherapy strategies.

    Recent studies, such as Chini et al. (2025), have revealed how mitochondrial DNA leakage under chronic NAD depletion activates a viral infection-like interferon response through the cGAS-STING pathway, underscoring the need for precise experimental tools like 2'3'-cGAMP to dissect these mechanisms.

    APExBIO’s 2'3'-cGAMP (sodium salt) (SKU: B8362) offers bench scientists a highly soluble, water-compatible, and chemically defined reagent for reliable activation of STING signaling across a range of cell types.

    Step-by-Step Experimental Workflow and Protocol Enhancements

    1. Preparation and Handling

    • Solubility: Dissolve 2'3'-cGAMP (sodium salt) in molecular-grade water (≥7.56 mg/mL) for optimal stock concentration. Avoid ethanol or DMSO, as the compound is insoluble in these solvents.
    • Aliquoting and Storage: Prepare single-use aliquots and store at -20°C to preserve stability and biological activity.
    • Working Solutions: Dilute stocks in pre-warmed culture medium immediately before use. Filter sterilize if necessary.

    2. Cell Stimulation Protocol

    1. Seed target cells (e.g., NIH3T3 fibroblasts, IMR90s, or HS5 stromal cells) to reach ~70% confluence at the time of treatment.
    2. Prepare serial dilutions of 2'3'-cGAMP to determine dose-response (typical range: 100 nM to 10 μM; EC50 values for STING activation are often observed between 0.1–1 μM depending on cell type).
    3. Apply 2'3'-cGAMP (sodium salt) to cultures via direct addition or liposome-mediated delivery for enhanced cytosolic uptake, especially in primary or non-phagocytic cells.
    4. Incubate for 4–24 hours. For time-course studies, collect samples at multiple intervals to monitor IFN-β mRNA and protein induction.
    5. Analyze downstream effectors (e.g., IFN-β, ISGs, phospho-IRF3) via qPCR, ELISA, and immunoblotting.

    3. Workflow Enhancements

    • Co-treat with known STING inhibitors (e.g., H-151) or VDAC oligomerization blockers (e.g., VBIT-4) to validate specificity and dissect upstream events, as performed in Chini et al. (2025).
    • Combine with mitochondrial DNA depletion protocols to confirm cGAS-STING pathway dependency.
    • Integrate cell viability and cytotoxicity assays (e.g., MTT, CellTiter-Glo®) to differentiate direct STING pathway effects from off-target toxicity, as recommended in the scenario guide by Enhancing cGAS-STING Assays.

    Advanced Applications and Comparative Advantages

    Dissecting Chronic Inflammatory Pathways and Immunotherapeutic Potential

    2'3'-cGAMP (sodium salt) is not merely a tool for acute pathway activation—it enables exploration of chronic or disease-mimetic states such as persistent NAD+ depletion and mitochondrial dysfunction, as demonstrated in the reference study. By modeling viral infection-like responses in vitro, researchers can unravel the interplay between metabolism, mitochondrial stress, and innate immunity—a crucial step toward novel immunotherapeutic interventions.

    In "2'3'-cGAMP (sodium salt): Precision STING Agonist for Innate Immunity", the molecule's gold-standard status is attributed to its unrivaled selectivity for mammalian STING, facilitating both high-throughput compound screening and detailed mechanistic studies in immunotherapy research. This complements the present workflow by providing benchmark data for potency and reproducibility against alternative cyclic dinucleotides.

    Benchmarking Against Alternative Agonists

    • Affinity: With a Kd of 3.79 nM, 2'3'-cGAMP exceeds the binding affinity and activation efficacy of bacterial CDNs (e.g., c-di-GMP, c-di-AMP).
    • Purity and Lot Consistency: APExBIO provides quality assurance, minimizing lot-to-lot variation and ensuring reproducible results—key for longitudinal studies and multi-center collaborations, as noted in this benchmarking guide.
    • Versatility: The compound supports research into both canonical (STING-dependent) and emerging non-canonical pathways, including effects on cell migration and cGAS-STING-independent signaling, as explored in Beyond Innate Immunity in Cell Migration.

    Troubleshooting and Optimization Tips

    Common Pitfalls and Solutions

    • Variable Response: If STING activation is inconsistent, verify cell line STING genotype and expression. Murine and human STING alleles differ in CDN responsiveness.
    • Poor Solubility or Precipitation: Always dissolve in water at room temperature. Use gentle vortexing and avoid repeated freeze-thaw cycles.
    • Low Signal-to-Noise: Optimize delivery—liposome-mediated or electroporation can enhance cytosolic access in less-permeable cells.
    • Off-Target Effects: Include negative controls (vehicle, inactive CDN) and pathway blockers. Confirm specificity via downstream readouts (e.g., phospho-TBK1, IRF3 nuclear translocation).
    • Batch Variability: Source from a reputable supplier such as APExBIO, as highlighted in Enhancing cGAS-STING Assays, to ensure product integrity and traceability.

    Optimizing for Sensitivity and Precision

    • Perform titration curves for each new cell batch to establish EC50 and dynamic range.
    • Validate activation via both mRNA (qPCR) and protein (ELISA, Western blot) endpoints for robust interpretation.
    • For high-content or screening applications, pair 2'3'-cGAMP with multiplexed readouts (e.g., Luminex assays) to capture broad immunomodulatory profiles.

    Future Outlook: Expanding the cGAS-STING Research Frontier

    The ability to model chronic metabolic stress, mitochondrial perturbations, and viral-mimetic inflammation using 2'3'-cGAMP (sodium salt) is opening new avenues in both basic and translational research. As evidenced by Chini et al. (2025), tools that accurately recapitulate endogenous innate immune signaling are critical for identifying new therapeutic targets in aging, cancer, and infectious diseases.

    Advanced applications now include:

    • Screening for small-molecule STING modulators in immunotherapy pipelines.
    • Modeling antiviral response pathways in primary human tissues.
    • Elucidating connections between cellular metabolism, DNA repair, and inflammation in chronic disease states.

    With its high purity, reproducibility, and compatibility with contemporary cell biology workflows, 2'3'-cGAMP (sodium salt) from APExBIO is poised to remain the benchmark STING agonist for the next generation of immunotherapy and innate immunity research.